Strongbridge Biopharma plc·4

Jan 29, 6:26 PM ET

Wilhoit Scott L. 4

4 · Strongbridge Biopharma plc · Filed Jan 29, 2020

Insider Transaction Report

Form 4
Period: 2020-01-27
Wilhoit Scott L.
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-01-27+200,000200,000 total
    Exercise: $2.98Exp: 2030-01-27Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]This option vests in sixteen equal quarterly installments beginning April 27, 2020, provided the Reporting Person is employed by the Issuer on each vesting date.

Documents

2 files